Hydroxychloroquine shows no benefit against coronavirus in N.Y. study

A decades-old malaria medicine touted by the president as a coronavirus treatment showed no benefit for patients hospitalized in New York.

There was also no noticeable advantage for patients that took the drug paired with the antibiotic azithromycin, according to hotly anticipated research published Monday in the Journal of the American Medical Association.

President Donald Trump had repeatedly championed hydroxychloroquine from the press briefing stage, saying it had "tremendous promise" and was safe because "it's been used for a long time."